INS and Insulin resistance: Currently, no single pediatric cardiometabolic risk assessment standard exists, but variables used to indicate risk often include one or more of glucose metabolism (fasting glucose, insulin, or insulin resistance, homeostatic model assessment of insulin resistance [HOMA-IR]), cholesterol (total cholesterol [TC]; high-density lipoproteins [HDL]), triglycerides (TG), and waist circumference (WC) (8–10).